Is The Rally Real? Scopus Biopharma Inc (NASDAQ:SCPS)

Scopus Biopharma Inc (NASDAQ:SCPS) stock is trading sharply higher on the FDA news on Monday.

Market Action

As of 10:26, SCPS stock soared by 136% at $14.10. The stock has traded 3.82 million shares, well above its average volume of 64K shares.  The stock opened at $5.74 and moved in a range of $ 5.74- 15.15.

SCPS Releases News

Scopus BioPharma Announces FDA Approval of IND Application for Lead Drug Candidate

  • SCPS announced the approval of an investigational new drug application (“IND”) by the United States Food and Drug Administration (“FDA”) for CpG-STAT3siRNA, the company’s distinctive immuno-oncology RNA therapy for the treatment of multiple cancers.
  • A Phase 1 clinical trial for B-cell non-Hodgkin lymphoma will be initiated at City of Hope.
  • CpG-STAT3siRNA encompasses both RNA therapy and immunotherapy by synthetically linking siRNA to an oligonucleotide TLR9 agonist, creating the potential for targeted gene silencing with simultaneous TLR stimulation and immune activation in the tumor microenvironment.

Trader Notes

Share Information

SHARES OUTSTANDING15.73 M
SHARE FLOAT (%)5.63 M (35.78%)
% HELD BY INSTITUTIONS3.69

Recent Stock Performance

5-DAY PERF.+153.74%
1-MONTH PERF.+92.99%
3-MONTH PERF.+56.71%
6-MONTH PERF.
YTD PERF.-1.68%
1-YEAR PERF.

Moving Averages

+/- EMA(20)6.98 (+109.03%)
+/- SMA(50)7.74 (+88.50%)
+/- SMA(200)10.08 (+44.74%)

Pivot Points

NameS3S2S1Pivot PointsR1R2R3
Classic5.54335.70675.83335.99676.12336.28676.4133
Fibonacci5.70675.81745.88595.99676.10746.17596.2867

Technical Indicators

SymbolValueResultSymbolValueResult
ADX33.9431SellATR140.4361
CCI20-27.6481NeutralChaikin Money Flow-0.3411Sell
MACD-0.5851SellMoney Flow Index36.3239Buy
ROC-4.7923SellRSI42.0976Buy
STOCH (14,3)41.9192BuySTOCH RSI0.9628OverBought
UO50.7204BuyWilliams %R-58.0808Neutral

Related Posts

About The Author